Readystate Asset Management’s Boston Scientific BSX Stock Holding History

Readystate Asset Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$452K	Hold	10,600	–	–	0.02%	686
2026 Q1	$665K	Buy	+10,600	New	+$848K	0.03%	534
2025 Q2	–	Sell	-36,400	Closed	-$3.67M	–	657
2025 Q1	$3.67M	Sell	36,400 -40,500	-53%	-$4.08M	0.12%	142
2024 Q4	$6.87M	Sell	76,900 -132,600	-63%	-$11.7M	0.21%	104
2024 Q3	$17.6M	Buy	209,500 +139,300	+198%	+$11M	0.33%	61
2024 Q2	$5.41M	Buy	70,200 +12,600	+22%	+$922K	0.18%	100
2024 Q1	$3.95M	Buy	+57,600	New	+$3.7M	0.06%	412
2023 Q2	–	Sell	-6,600	Closed	-$330K	–	295
2023 Q1	$330K	Buy	+6,600	New	+$311K	0.03%	191

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Readystate Asset Management's BSX Position: Q2 2026 in Review

Readystate Asset Management increased its Boston Scientific (BSX) stake by 163% in Q2 2026, buying an estimated $314K and bringing the position to 9,321 shares worth $398K. The position accounts for 0.01% of the portfolio, ranked #711.

Readystate Asset Management first reported a position in BSX in Q1 2025 and has held it in 3 quarters since. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Readystate Asset Management held 9,321 shares of Boston Scientific worth $398K as of Q2 2026.
Readystate Asset Management bought 5,781 Boston Scientific shares in Q2 2026, an estimated $314K.
Boston Scientific made up 0.01% of Readystate Asset Management's portfolio in Q2 2026, its #711 holding.
Readystate Asset Management first reported a position in Boston Scientific in Q1 2025 and has held it in 3 quarters since.
1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Readystate Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.